The U.S. military has reportedly developed a vaccine that is highly effective against COVID, including all its variants.

Washington, December 22 (RHC)-- The U.S. military has reportedly developed a vaccine that is highly effective against COVID, including all its variants. 

The vaccine, created over two years at the Walter Reed Army Institute of Research, is also said to be effective against other SARS-origin viruses. A public announcement with more information about the vaccine is expected in the coming weeks.

Meanwhile, Oxfam America, a Moderna shareholder, has filed a complaint against the drug company with the Securities and Exchange Commission.  A lawyer for Oxfam said: “Instead of … using its life-saving technology to help curb the pandemic, Msoderna is … obfuscating its patent dispute with the US government, ignoring the death and suffering of millions worldwide, and declining to share their technology to help alleviate the stranglehold that COVID-19 has placed on the global economy.”

In other vaccine news, European Union regulators have approved Novavax’s vaccine for people 18 and older.  Tests have shown the U.S.-developed shot to be roughly 90% effective, though there is limited data on its efficacy against variants of concern, including Omicron.  Novavax will start delivering vaccines to the EU in January.